Company Filing History:
Years Active: 2019-2022
Title: Innovations by Jason Kim in Targeted Therapeutics
Introduction
Jason Kim, an innovative inventor based in Austin, Texas, has made significant contributions to the field of targeted therapeutics. With a remarkable portfolio of 8 patents, he specializes in developing cell-targeting molecules aimed at enhancing immune responses and treating various diseases, including cancer.
Latest Patents
Among his latest inventions are two groundbreaking patents. The first patent, titled "Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ T-cell epitopes," presents a novel method for delivering CD8+ T-cell epitope cargo to the MHC class I presentation pathway of target cells. These molecules can selectively label or kill specific cell types, including malignant and non-immune cells, and hold promise for treating cancers, immune disorders, and microbial infections.
The second patent, "Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof," focuses on multivalent CD20-binding molecules designed for the selective killing of particular cell types. These therapeutics can be utilized to deliver agents into CD20-expressing cells, and they play a crucial role in diagnosing and monitoring treatment responses for diseases such as cancers and immune disorders.
Career Highlights
Jason Kim's career is anchored by his role at Molecular Templates, Inc., where he leverages his expertise in therapeutic development. His innovative work has positioned him as a prominent figure in the field of biopharmaceuticals, contributing to advancements that push the boundaries of standard treatments.
Collaborations
In his quest for innovation, Jason collaborates with esteemed colleagues, including Eric Poma and Erin Willert, enhancing the research and development efforts at Molecular Templates. These collaborative endeavors underscore the importance of teamwork and collective expertise in driving forward the innovations that can dramatically improve patient outcomes.
Conclusion
Jason Kim stands out as an influential inventor whose patents reflect his commitment to improving healthcare through targeted therapeutics. His continuous work at Molecular Templates, Inc. and collaborations with other experts promise to yield further breakthroughs in the treatment of complex diseases, ultimately advancing the field of medicine.